Diarrhea in pediatric recipients of solid organ or bone marrow transplants.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
29 Oct 2021
Historique:
received: 28 06 2021
accepted: 14 10 2021
entrez: 29 10 2021
pubmed: 30 10 2021
medline: 6 11 2021
Statut: ppublish

Résumé

Diarrhea is common in adults after solid organ transplantation (SOT) and bone marrow transplantation (BMT), but data in children are limited. Therefore, we aimed to determine the incidence and etiology of pediatric early-onset diarrhea in post SOT and BMT.We reviewed children aged 6 months to 18 years who underwent liver transplantation, kidney transplantation or BMT between January 2015 and December 2019 with duration of diarrhea > 72 hours within the first 6 months after transplantation. Clinical data and diarrheal course were collected. Regression analyses were performed to define factors associated with the interested outcomes.Among 252 transplanted patients, 168 patients (66.6%) had 289 documented episodes of diarrhea. A diagnosis of 68.2% of post-transplant diarrhea remained 'indefinite'. Enteric infection in SOT and gastrointestinal acute graft-versus-host disease (GI-aGVHD) in BMT were the commonly identified etiologies. Among 182 episodes among BMT children, skin rash was more pronounced when compared the ones with diarrhea > 7 days vs ≤ 7 days (odds ratio [OR] 13.9; 95% CI 1.8, 107.6). Males were more likely to develop GI-aGVHD as compared to females (OR 8.9). We found that GI-aGVHD was more common in the ones with skin rash and the presence of white blood cells in stool examination (OR 8.4 and 3.1, respectively). Deaths occurred in 7.7%.Two-thirds of post-transplant children experienced at least one episode of early-onset diarrhea, of which the etiology mainly remains undefined. Various clinical factors of prolonged/chronic diarrhea and GI-aGVHD may help clinicians when managing these children.

Identifiants

pubmed: 34713851
doi: 10.1097/MD.0000000000027625
pii: 00005792-202110290-00031
pmc: PMC8556011
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27625

Informations de copyright

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding and conflicts of interest to disclose.

Références

Kamboj M, Mihu CN, Sepkowitz K, et al. Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield. Transpl Infect Dis 2007;9:265–9.
Hardinger KL, Brennan DC, Lowell J, et al. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int 2004;17:609–16.
Bunnapradist S, Neri L, Wong W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis 2008;51:478–86.
Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl 2005;11:881–90.
Chaudhuri A, Goddard EA, Green M, et al. Diarrhea in the pediatric solid organ transplantation recipient: a multidisciplinary approach to diagnosis and management. Pediatr Transplant 2021;25:e13886.
Pescovitz MD, Navarro MT. Immunosuppressive therapy and post-transplantation diarrhea. Clin Transplant 2001;15:23–8.
Gil-Vernet S, Amado A, Ortega F, et al. Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc 2007;39:2190–3.
Diaz B, Gonzalez Vilchez F, Almenar L, et al. Gastrointestinal complications in heart transplant patients: MITOS study. Transplant Proc 2007;39:2397–400.
Herrero JI, Benlloch S, Bernardos A, et al. Gastrointestinal complications in liver transplant recipients: MITOS study. Transplant Proc 2007;39:2311–3.
Bravo C, Gispert P, Borro JM, et al. Prevalence and management of gastrointestinal complications in lung transplant patients: MITOS study group. Transplant Proc 2007;39:2409–12.
Pant C, Deshpande A, Larson A. Diarrhea in solid-organ transplant recipients: a review of the evidence. Curr Med Res Opin 2013;29:1315–28.
Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients: results of the DIDACT study. Am J Transplant 2006;6:1466–72.
Arslan H, Inci EK, Azap OK, et al. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis 2007;9:270–5.
Vyas VD, Parameswaran SA, Paramasiwan P, et al. Etiological profile of diarrhea in solid organ transplant recipients at a tertiary care center in Southern India. Transpl Infect Dis 2021;16:e13584.
Barker CC, Anderson RA, Sauve RS, Butzner JD. GI complications in pediatric patients post-BMT. Bone Marrow Transplant 2005;36:51–8.
Guarino A, Ashkenazi S, Gendrel D, et al. European society of pediatric gastroenterology, hepatology and nutrition/European society for pediatric infectious disease evidence-based guidelines for management of acute gastroenteritis in children in Europe: update. J Pediatr Gastroenterol Nutr 2014;59:132–52.
Michel D, Marre E, Hampl W, et al. Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples. J Clin Microbiol 1995;33:3064–7.
Neejara K, John PH, Sundram U, et al. Hematopoietic stem cell transplantation: graft versus host disease and pathology of gastrointestinal tract, liver, and lung. Adv Anat Pathol 2014;21:301–20.
Berger T, Giladi O, Yahav D, et al. Diarrheal morbidity during hematopoietic cell transplantation: the diagnostic yield of stool cultures. Infect Dis Ther 2021;4.doi: 10.1007/s40121-021-00415-9.
doi: 10.1007/s40121-021-00415-9
Buss SN, Leber A, Chapin K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol 2015;53:915–25.
Coste J-F, Vuiblet V, Moustapha B, et al. Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex PCR assays. J Clin Microbiol 2013;51:1841–9.
Gale RP, Bortin MM, Bekkum DW, van, et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987;67:397–406.
Flower ME, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011;117:3214–9.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH